Associations between adipocyte fatty acid-binding protein and clinical parameters in polycystic ovary syndrome

被引:0
作者
Melike Doğanay
Sebnem Sen Ozyer
Turgut Var
Esra Tonguc
Ozlem Gun Eryilmaz
Irfan Ozer
Ali Irfan Guzel
机构
[1] Zekai Tahir Burak Women’s Health Education and Research Hospital,Department of Gynecology
来源
Archives of Gynecology and Obstetrics | 2015年 / 291卷
关键词
Polycystic ovary syndrome; Adipocyte fatty acid-binding protein; Metabolic syndrome; Obesity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:447 / 450
页数:3
相关论文
共 89 条
[11]  
Reyna R(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 41-396
[12]  
Key TJ(2009)FABP4: a novel candidate gene for polycystic ovary syndrome Endocrine 36 392-147
[13]  
Knochenhauer ES(2002)Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis Curr Opin Lipidol 13 141-1922
[14]  
Yıldız BO(2006)Regulation of metabolic responses by adipocyte/macrophage: fatty acid-binding proteins in leptin deficient mice Diabetes 55 1915-867
[15]  
Franks S(2006)Inflammation and metabolic disorders Nature 444 860-1379
[16]  
Dunaif A(1996)Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein Science 274 1377-E823
[17]  
Legro RS(2006)Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice Am J Physiol Endocrinol Metab 290 E814-202
[18]  
Barber TM(2011)Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome Endocrine 40 196-200
[19]  
McCarthy MI(2007)Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women Eur J Endocrinol 157 195-939
[20]  
Wass JA(2011)Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess Gynecol Endocrinol 27 935-274